RecallRadar

FDA Drug recall D-0543-2025

Timolol Maleate Ophthalmic Solution USP, 0.5%, Sterile, 5mL bottles, Rx only, Manufactured by: FDC Limited, Waluj, Aurangabad, Maharashtra,…

On 2025-08-06 the FDA classified a Class II recall of Timolol Maleate Ophthalmic Solution USP, 0.5%, Sterile, 5mL bottles, Rx only, Manufactured by: FDC Limited, Waluj, Aurangabad, Maharashtra,… by Fdc, citing defective Container: spike of the cap becomes lodged in the nozzle of the product bottle.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0543-2025
ClassificationClass II
Statusongoing
Initiated2025-07-05
Published2025-08-06
Last updated2026-09-13 11:52 UTC
CompanyFdc
DistributionUS

Product

Timolol Maleate Ophthalmic Solution USP, 0.5%, Sterile, 5mL bottles, Rx only, Manufactured by: FDC Limited, Waluj, Aurangabad, Maharashtra, India, Distributed by: Rising Pharmaceuticals Inc, New Jersey, NDC 64980-514-05.

Reason

Defective Container: spike of the cap becomes lodged in the nozzle of the product bottle.

Identifiers

ndc64980-513-05
ndc64980-513-01
ndc64980-513-15
ndc64980-514-05
ndc64980-514-01
ndc64980-514-15
code_infoLot#: 083L061, Exp.: 11/2025.

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0543-2025%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.